Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

OR11H1 Inhibitors

The classification OR11H1 Inhibitors would refer to a group of chemical compounds designed or discovered to modulate, specifically inhibit, the activity of the OR11H1 protein, an olfactory receptor. The purpose of such inhibitors could be to alter or block the normal interaction between OR11H1 and odorant molecules, thereby inhibiting the initiation of the neuronal response that leads to the perception of a smell. Given the G-protein-coupled receptor (GPCR) nature of OR11H1, these inhibitors might operate through various mechanisms typical to GPCR modulation, like antagonism, inverse agonism, or allosteric modulation. Antagonists, for instance, could block the active site of OR11H1, preventing the binding of odorant molecules, while inverse agonists could inhibit the receptor's activity even in the absence of a ligand. Allosteric modulators might bind to a different site on the receptor, changing its conformation and potentially its interaction with odorant molecules. While the concept of OR11H1 Inhibitors is straightforward in theory, the precise identification, characterization, and understanding of such compounds could be complex. The interaction between olfactory receptors like OR11H1 and odorant molecules is a finely tuned process, with a delicate balance of activations and inhibitions that enable the nuanced perception of smell. Chemical compounds capable of inhibiting OR11H1 would need to be studied rigorously to understand their selectivity, specificity, and the extent of inhibition they provide without affecting other olfactory receptors or GPCRs. Moreover, the broader biological and physiological implications of inhibiting an olfactory receptor like OR11H1 would also warrant a thorough investigation. The field of olfactory receptor modulation, including the discovery and understanding of OR11H1 Inhibitors, presents a rich avenue for exploratory research in molecular and sensory biology.

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Carvedilol

72956-09-3sc-200157
sc-200157A
sc-200157B
sc-200157C
sc-200157D
100 mg
1 g
10 g
25 g
100 g
$122.00
$235.00
$520.00
$979.00
$1500.00
2
(1)

As an inverse agonist, carvedilol might inhibit OR11H1's activity even in the absence of a ligand, potentially reducing olfactory signaling.

Propranolol

525-66-6sc-507425
100 mg
$180.00
(0)

As a beta-blocker, propranolol might antagonize OR11H1, potentially blocking its activation by odorant molecules.

Alprenolol hydrochloride

13707-88-5sc-203503
sc-203503A
sc-203503B
sc-203503C
50 mg
100 mg
200 mg
500 mg
$115.00
$193.00
$300.00
$669.00
2
(1)

Alprenolol, being a beta-blocker, might act as an antagonist to OR11H1, possibly inhibiting its activation by odorant molecules.

Olmesartan acid

144689-24-7sc-219481
sc-219481A
sc-219481B
sc-219481C
sc-219481D
10 mg
500 mg
1 g
2 g
5 g
$153.00
$204.00
$326.00
$523.00
$1051.00
7
(1)

Olmesartan acid might act as an antagonist, potentially blocking OR11H1 activation and reducing olfactory signaling.

Losartan

114798-26-4sc-353662
100 mg
$127.00
18
(1)

Losartan could potentially act as an antagonist, inhibiting OR11H1 activation and possibly affecting olfactory signaling.

Valsartan

137862-53-4sc-220362
sc-220362A
sc-220362B
10 mg
100 mg
1 g
$39.00
$90.00
$120.00
4
(1)

Valsartan might act as an antagonist to OR11H1, potentially inhibiting its activation by odorant molecules.

Telmisartan

144701-48-4sc-204907
sc-204907A
50 mg
100 mg
$71.00
$92.00
8
(1)

Telmisartan could act as an antagonist, possibly blocking OR11H1 activation and affecting olfactory signaling.

Labetalol

36894-69-6sc-484723
50 mg
$176.00
(0)

Labetalol, as a beta-blocker, might antagonize OR11H1, potentially inhibiting its activation by odorant molecules.

Nebivolol

99200-09-6sc-279910
100 mg
$803.00
1
(0)

Nebivolol might act as a beta-blocker, potentially antagonizing OR11H1 and inhibiting its activation by odorant molecules.

Sotalol hydrochloride

959-24-0sc-203699
sc-203699A
10 mg
50 mg
$67.00
$246.00
3
(1)

Sotalol hydrochloride, being a beta-blocker, might antagonize OR11H1, possibly inhibiting its activation by odorant molecules.